Doctor education may boost use of cheaper biologic drugs

This study looks at whether offering doctors educational meetings about biosimilar medications leads them to prescribe more of these lower-cost alternatives instead of the original brand-name drugs. About 1,325 clinicians who prescribe adalimumab for conditions like rheumatoid arthritis and psoriasis will be offered in-person or virtual sessions with a trained educator. The goal is to see if this approach increases biosimilar use and reduces costs for patients and insurers.